| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/12/2023 | 7.11% | Morgan Stanley | $27 → $36 | Upgrades | Underweight → Equal-Weight |
| 06/28/2023 | -19.67% | Morgan Stanley | $27 → $27 | Reiterates | Underweight → Underweight |
| 06/21/2023 | -19.67% | Morgan Stanley | → $27 | Reiterates | → Underweight |
| 06/13/2023 | 33.89% | Oppenheimer | $40 → $45 | Maintains | Outperform |
| 04/12/2023 | -19.67% | Morgan Stanley | $28 → $27 | Downgrades | Equal-Weight → Underweight |
| 04/06/2023 | 19.01% | Oppenheimer | $42 → $40 | Maintains | Outperform |
| 03/24/2023 | 24.96% | Oppenheimer | $48 → $42 | Maintains | Outperform |
| 01/11/2023 | 19.01% | Goldman Sachs | → $40 | Downgrades | Buy → Neutral |
| 12/22/2022 | 10.09% | Keefe, Bruyette & Woods | $38 → $37 | Downgrades | Outperform → Market Perform |
| 08/04/2022 | 10.09% | Goldman Sachs | $33 → $37 | Maintains | Buy |
| 07/19/2022 | -16.69% | Morgan Stanley | $32 → $28 | Maintains | Equal-Weight |
| 06/28/2022 | -4.79% | Morgan Stanley | $33 → $32 | Maintains | Equal-Weight |
| 06/07/2022 | 39.84% | Oppenheimer | $50 → $47 | Maintains | Outperform |
| 03/18/2022 | 39.84% | Oppenheimer | $52 → $47 | Maintains | Outperform |
| 03/08/2022 | 4.14% | Morgan Stanley | $40 → $35 | Maintains | Equal-Weight |
| 12/16/2021 | 19.01% | Morgan Stanley | → $40 | Initiates Coverage On | → Equal-Weight |
| 11/16/2021 | 36.86% | Keefe, Bruyette & Woods | → $46 | Downgrades | Outperform → Market Perform |
| 10/01/2021 | 21.99% | Oppenheimer | $40 → $41 | Maintains | Outperform |
| 09/21/2021 | 33.89% | Goldman Sachs | → $45 | Initiates Coverage On | → Buy |
| 09/16/2020 | -37.52% | Keefe, Bruyette & Woods | → $21 | Upgrades | Market Perform → Outperform |
| 06/30/2020 | -22.64% | Oppenheimer | $25 → $26 | Maintains | Outperform |
| 07/11/2019 | -31.57% | Keefe, Bruyette & Woods | → $23 | Assumes | → Market Perform |
| 08/21/2018 | -13.72% | Keefe, Bruyette & Woods | → $29 | Initiates Coverage On | → Outperform |
What is the target price for Jefferies Financial Gr (JEF)?
The latest price target for Jefferies Financial Gr (NYSE: JEF) was reported by Morgan Stanley on July 12, 2023. The analyst firm set a price target for $36.00 expecting JEF to rise to within 12 months (a possible 7.11% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Jefferies Financial Gr (JEF)?
The latest analyst rating for Jefferies Financial Gr (NYSE: JEF) was provided by Morgan Stanley, and Jefferies Financial Gr upgraded their equal-weight rating.
When is the next analyst rating going to be posted or updated for Jefferies Financial Gr (JEF)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Jefferies Financial Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Jefferies Financial Gr was filed on July 12, 2023 so you should expect the next rating to be made available sometime around July 12, 2024.
Is the Analyst Rating Jefferies Financial Gr (JEF) correct?
While ratings are subjective and will change, the latest Jefferies Financial Gr (JEF) rating was a upgraded with a price target of $27.00 to $36.00. The current price Jefferies Financial Gr (JEF) is trading at is $33.61, which is within the analyst's predicted range.